Annual Cash & Cash Equivalents
N/A
December 1, 2024
Summary
- ABBV annual cash & cash equivalents is not available.
Performance
ABBV Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
N/A
December 1, 2024
Summary
- ABBV quarterly cash and cash equivalents is not available.
Performance
ABBV Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ABBV Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
ABBV Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time |
AbbVie Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $7.26 B(-44.7%) |
| Jun 2024 | - | $13.13 B(-27.3%) |
| Mar 2024 | - | $18.07 B(+41.0%) |
| Dec 2023 | $12.81 B(+39.3%) | $12.81 B(-3.6%) |
| Sep 2023 | - | $13.29 B(+51.7%) |
| Jun 2023 | - | $8.76 B(+30.5%) |
| Mar 2023 | - | $6.71 B(-27.1%) |
| Dec 2022 | $9.20 B(-5.6%) | $9.20 B(-22.2%) |
| Sep 2022 | - | $11.83 B(+38.9%) |
| Jun 2022 | - | $8.52 B(+39.7%) |
| Mar 2022 | - | $6.10 B(-37.4%) |
| Dec 2021 | $9.75 B(+15.4%) | $9.75 B(-20.0%) |
| Sep 2021 | - | $12.18 B(+42.5%) |
| Jun 2021 | - | $8.55 B(-12.4%) |
| Mar 2021 | - | $9.76 B(+15.5%) |
| Dec 2020 | $8.45 B(-78.8%) | $8.45 B(+7.1%) |
| Sep 2020 | - | $7.89 B(+31.1%) |
| Jun 2020 | - | $6.02 B(-85.4%) |
| Mar 2020 | - | $41.14 B(+3.1%) |
| Dec 2019 | $39.92 B(+447.7%) | $39.92 B(+274.9%) |
| Sep 2019 | - | $10.65 B(+105.9%) |
| Jun 2019 | - | $5.17 B(+5.6%) |
| Mar 2019 | - | $4.90 B(-32.8%) |
| Dec 2018 | $7.29 B | $7.29 B(-9.1%) |
| Sep 2018 | - | $8.02 B(+126.0%) |
| Jun 2018 | - | $3.55 B(-60.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2018 | - | $9.01 B(-3.2%) |
| Dec 2017 | $9.30 B(+82.4%) | $9.30 B(+10.1%) |
| Sep 2017 | - | $8.45 B(+38.7%) |
| Jun 2017 | - | $6.09 B(+28.4%) |
| Mar 2017 | - | $4.74 B(-7.1%) |
| Dec 2016 | $5.10 B(-39.3%) | $5.10 B(-18.0%) |
| Sep 2016 | - | $6.22 B(-1.7%) |
| Jun 2016 | - | $6.33 B(-16.3%) |
| Mar 2016 | - | $7.56 B(-10.0%) |
| Dec 2015 | $8.40 B(+0.6%) | $8.40 B(-8.9%) |
| Sep 2015 | - | $9.22 B(+24.6%) |
| Jun 2015 | - | $7.40 B(-6.4%) |
| Mar 2015 | - | $7.91 B(-5.3%) |
| Dec 2014 | $8.35 B(-13.0%) | $8.35 B(+8.1%) |
| Sep 2014 | - | $7.72 B(-15.0%) |
| Jun 2014 | - | $9.09 B(+11.6%) |
| Mar 2014 | - | $8.14 B(-15.2%) |
| Dec 2013 | $9.60 B(+62.6%) | $9.60 B(+6.9%) |
| Sep 2013 | - | $8.97 B(+2.7%) |
| Jun 2013 | - | $8.74 B(+25.3%) |
| Mar 2013 | - | $6.98 B(+18.3%) |
| Dec 2012 | $5.90 B(>+9900.0%) | $5.90 B(+113.7%) |
| Sep 2012 | - | $2.76 B(+3604.2%) |
| Jun 2012 | - | $74.54 M(+81.8%) |
| Mar 2012 | - | $41.00 M(+51.8%) |
| Dec 2011 | $27.00 M(+180.0%) | $27.00 M |
| Dec 2010 | $9.64 M | - |
FAQ
- What is the all time high annual cash & cash equivalents for AbbVie?
- What is the all time high quarterly cash and cash equivalents for AbbVie?
What is the all time high annual cash & cash equivalents for AbbVie?
AbbVie all-time high annual cash & cash equivalents is $39.92 B
What is the all time high quarterly cash and cash equivalents for AbbVie?
AbbVie all-time high quarterly cash and cash equivalents is $41.14 B